Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Almut G Winterstein

Showing results (81-90 of 266) with videos related to

Pageof 27
Sort By:
JAMA Network Open|January 16, 2019
Prevalence of and Factors Associated With Long-term Concurrent Use of Stimulants and Opioids Among Adults With Attention-Deficit/Hyperactivity DisorderYu-Jung Jenny Wei, Yanmin Zhu, Wei Liu, et al.
Journal of Attention Disorders|August 14, 2015
Psychotropic Treatment Pattern in Medicaid Pediatric Patients With Concomitant ADHD and ODD/CDXinyue Liu, Vaishali Shah, Paul Kubilis, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 26, 2005
Causes of hyperglycemia and hypoglycemia in adult inpatientsWendy D Smith, Almut G Winterstein, Thomas Johns, et al.
International Journal of Antimicrobial Agents|May 20, 2017
Acute kidney injury risk associated with piperacillin/tazobactam compared with cefepime during vancomycin therapy in hospitalised patients: a cohort study stratified by baseline kidney functionNakyung Jeon, Ben Staley, Kenneth P Klinker, et al.
The Annals of Pharmacotherapy|February 1, 2007
Efficacy and safety of oral phenylephrine: systematic review and meta-analysisRandy C Hatton, Almut G Winterstein, Russell P McKelvey, et al.
Annals of Internal Medicine|March 20, 2023
Assessment of the Risk Evaluation and Mitigation Strategy (REMS) for Phentermine-Topiramate to Prevent Exposure During PregnancyAmir Sarayani, William Troy Donahoo, Christian Hampp, et al.
JAMA Internal Medicine|April 19, 2021
Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing TrendsPhuong T Tran, Patrick J Antonelli, Juan M Hincapie-Castillo, et al.
The Annals of Pharmacotherapy|August 2, 2007
Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory careLinda Aagaard Thomsen, Almut G Winterstein, Birthe Søndergaard, et al.
BMC Infectious Diseases|August 8, 2022
RSV testing practice and positivity by patient demographics in the United States: integrated analyses of MarketScan and NREVSS databasesPhuong T Tran, Sabina O Nduaguba, Vakaramoko Diaby, et al.
Drug Safety|November 1, 2022
Topiramate Utilization After Phentermine/Topiramate Approval for Obesity Management: Risk Minimization in the Era of Drug RepurposingAmir Sarayani, Christian Hampp, Joshua D Brown, et al.
Pageof 27

Showing results (81-90 of 266) with videos related to

Sort By:
Pageof 27
JAMA Network Open|January 16, 2019
Prevalence of and Factors Associated With Long-term Concurrent Use of Stimulants and Opioids Among Adults With Attention-Deficit/Hyperactivity DisorderYu-Jung Jenny Wei, Yanmin Zhu, Wei Liu, et al.
Journal of Attention Disorders|August 14, 2015
Psychotropic Treatment Pattern in Medicaid Pediatric Patients With Concomitant ADHD and ODD/CDXinyue Liu, Vaishali Shah, Paul Kubilis, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 26, 2005
Causes of hyperglycemia and hypoglycemia in adult inpatientsWendy D Smith, Almut G Winterstein, Thomas Johns, et al.
International Journal of Antimicrobial Agents|May 20, 2017
Acute kidney injury risk associated with piperacillin/tazobactam compared with cefepime during vancomycin therapy in hospitalised patients: a cohort study stratified by baseline kidney functionNakyung Jeon, Ben Staley, Kenneth P Klinker, et al.
The Annals of Pharmacotherapy|February 1, 2007
Efficacy and safety of oral phenylephrine: systematic review and meta-analysisRandy C Hatton, Almut G Winterstein, Russell P McKelvey, et al.
Annals of Internal Medicine|March 20, 2023
Assessment of the Risk Evaluation and Mitigation Strategy (REMS) for Phentermine-Topiramate to Prevent Exposure During PregnancyAmir Sarayani, William Troy Donahoo, Christian Hampp, et al.
JAMA Internal Medicine|April 19, 2021
Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing TrendsPhuong T Tran, Patrick J Antonelli, Juan M Hincapie-Castillo, et al.
The Annals of Pharmacotherapy|August 2, 2007
Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory careLinda Aagaard Thomsen, Almut G Winterstein, Birthe Søndergaard, et al.
BMC Infectious Diseases|August 8, 2022
RSV testing practice and positivity by patient demographics in the United States: integrated analyses of MarketScan and NREVSS databasesPhuong T Tran, Sabina O Nduaguba, Vakaramoko Diaby, et al.
Drug Safety|November 1, 2022
Topiramate Utilization After Phentermine/Topiramate Approval for Obesity Management: Risk Minimization in the Era of Drug RepurposingAmir Sarayani, Christian Hampp, Joshua D Brown, et al.
Pageof 27